rs1393503590
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5
The NM_206933.4(USH2A):āc.1550G>Cā(p.Arg517Thr) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,612,958 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_206933.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USH2A | NM_206933.4 | c.1550G>C | p.Arg517Thr | missense_variant, splice_region_variant | 8/72 | ENST00000307340.8 | NP_996816.3 | |
USH2A | NM_007123.6 | c.1550G>C | p.Arg517Thr | missense_variant, splice_region_variant | 8/21 | NP_009054.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.1550G>C | p.Arg517Thr | missense_variant, splice_region_variant | 8/72 | 1 | NM_206933.4 | ENSP00000305941 | P1 | |
USH2A | ENST00000366942.3 | c.1550G>C | p.Arg517Thr | missense_variant, splice_region_variant | 8/21 | 1 | ENSP00000355909 | |||
USH2A | ENST00000674083.1 | c.1550G>C | p.Arg517Thr | missense_variant, splice_region_variant | 8/73 | ENSP00000501296 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151788Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250598Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135404
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461170Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 726902
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151788Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74108
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 05, 2023 | This sequence change replaces arginine, which is basic and polar, with threonine, which is neutral and polar, at codon 517 of the USH2A protein (p.Arg517Thr). This variant also falls at the last nucleotide of exon 8, which is part of the consensus splice site for this exon. This variant is present in population databases (no rsID available, gnomAD 0.002%). This missense change has been observed in individuals with Usher syndrome or non-syndromic retinal disease (PMID: 15325563, 15671307, 20507924; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 552769). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 19, 2024 | Last nucleotide of an exon in a gene, for which loss of function is a known mechanism of disease, and both splice predictors and evolutionary conservation support a deleterious effect; in the absence of functional evidence, the actual effect of this sequence change is unknown; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25525159, 20507924, 15671307, 32037395, 15325563, 34906470) - |
Retinitis pigmentosa 39 Pathogenic:1Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 20, 2024 | - - |
Uncertain significance, criteria provided, single submitter | research | Ocular Genomics Institute, Massachusetts Eye and Ear | Apr 08, 2021 | The USH2A c.1550G>C variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PM2, PP3. Based on this evidence we have classified this variant as Variant of Uncertain Significance. - |
Usher syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 26, 2023 | Variant summary: USH2A c.1550G>C (p.Arg517Thr) results in a non-conservative amino acid change located in the Laminin, N-terminal domain (IPR008211) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. In addition, this variant disrupts the last nucleotide of exon 8, and therefore can affect splicing. Computational tools predict no significant impact on normal splicing. However, this precludes an exact estimation of the computational splicing impact. The variant allele was found at a frequency of 4e-06 in 250598 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1550G>C has been reported in the literature in multiple individuals affected with Usher Syndrome and inherited retinal degeneration, including three homozygotes (two in one family) (e.g., Seyedahmadi_2004, Schwartz_2005, Zampaglione_2020). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 16963483, 20507924, 15671307, 15325563, 32037395). Five ClinVar submitters (evaluation after 2014) have reported the variant with conflicting interpretations: four submitters classified the variant as uncertain significance, and one submitter classified it as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Usher syndrome type 2A Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Nov 16, 2021 | NM_206933.2(USH2A):c.1550G>C(R517T) is a missense variant classified as a variant of uncertain significance in the context of USH2A-related disorders. R517T has been observed in cases with relevant disease (PMID: 15671307, 15325563). Functional assessments of this variant are not available in the literature. R517T has been observed in population frequency databases (gnomAD: NFE <0.001%). In summary, there is insufficient evidence to classify NM_206933.2(USH2A):c.1550G>C(R517T) as pathogenic or benign. Please note: this variant was assessed in the context of healthy population screening. - |
Retinal dystrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Blueprint Genetics | Jan 04, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at